News: immunotherapy

Fighting cancer from within

CISL Team

Lung cancer is the leading cause of cancer-related deaths in ÐÓ°ÉÖ±²¥, taking the lives of an estimated 8,900 people last year alone. 

[Read more about Fighting cancer from within]

SAiGENCI researcher awarded funding in latest MRFF round

Dr Yannan Yang

A SAiGENCI project using nanotechnology has received funding in the latest round of Medical Research Future Fund (MRFF) Early-to-Mid Career Researchers funding.

[Read more about SAiGENCI researcher awarded funding in latest MRFF round]

SAiGENCI recruit recognised with prestigious award

Professor Jenkins has been appointed as the Program Head for the Tumour Inflammation and Immunotherapy Program at the South ÐÓ°ÉÖ±²¥n ImmunoGENomics Cancer Institute (SAiGENCI), which operates within the ÐÓ°ÉÖ±²¥ of Adelaide’s Faculty of Health and Medical Sciences, and is supported by an alliance with the Central Adelaide Local Health Network (CALHN).

[Read more about SAiGENCI recruit recognised with prestigious award]

RSS News Feed